National Cancer Institute Microbiome measurements in epidemiological studies.

17
National Cancer Institute Microbiome measurements in epidemiological studies

Transcript of National Cancer Institute Microbiome measurements in epidemiological studies.

Page 1: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Microbiome measurements in epidemiological studies

Page 2: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Chronic Disease EpidemiologyChronic Disease Epidemiology

• Etiologic studies focused on understanding the association between diet, lifestyle, environmental exposures, genetics, etc. and the risk of cancer, heart disease, …• e.g. Helicobacter pylori and gastric cancer• Chronic Hp infection has multiple outcomes• Multiple cancer associations• Burn out

Page 3: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

1. Study design - prospective2. Efficient biosample collections3. Stability of exposure metrics4. Replication of findings

Page 4: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

1. Study design – prospective• For many exposures, optimal studies are prospective

• exposure information collected when subjects are ‘healthy’

• For cancer, it requires very large sample sizes• cancer is a rare disease• 50,000 – 500,000 subjects

• Most biosamples are never measured

Page 5: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

2. Efficient collection of large number of subjects• often completed at home• most previous studies had one contact

• or contact every 4-5 years• or more frequent contact with a subset of subjects

• oral microbiome collections?• fecal microbiome collections?• Absolute abundance

• How to normalize?

Page 6: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

3. Stability of exposure metrics• we need exposure metrics that are ‘the same’ when

measured (6, 12, 24, …) months apart

• The intraclass correlation coefficient (ICC) is very useful• systolic and diastolic blood pressure

• 0.87 and 0.77 between operators • 0.91 and 0.77 between devices• >0.60 in an individual when measured 12 months apart

Page 7: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Intraclass correlation coefficient (ICC)

Page 8: National Cancer Institute Microbiome measurements in epidemiological studies.

Temporal Variability and Implications to Epidemiological Studies

• Intraclass correlation coefficient (ICC)– A set of subjects with two time-points measurement. – For a given feature (relative abundance, α/β-diversity), let

be between-subject variance and be within-subject variance. – ICC =

• ICC ~ effective sample size for epidemiological Studies

• Human microbiome project (HMP)– Subjects with two visits, 18 body sites– linear mixed model, adjusting for age/sex/sequencing center

2b

2w

)/( 222wbb

1000 cases + 1000 controlsICC = 0.8

2000 cases + 2000 controlsICC = 0.4=

power

Page 9: National Cancer Institute Microbiome measurements in epidemiological studies.

Actinobact

eria

Bactero

idetes

Firmicu

tes

Fuso

bacteri

a

Proteo

bacteri

a

PD_tree

Chao1

Observe

d_speci

es

Shan

non_index

Unweighted

Weig

hted0

0.10.20.30.40.50.60.70.8

0.51 0.48

0.610000000000001

0.52

0.650000000000001

0.570.47 0.440.48 0.5 0.48

0.690000000000001

0.520.45

0.4

0.640000000000001

0.47 0.5

0.610000000000001

0.4

NCI_Stool HMP_Stool HMP_Oral HMP_Anteriornares HMP_Skin HMP_Vagina

relative abundance α-diversity β-diversity

ICC

Temporal Variability Based on HMP Data

Page 10: National Cancer Institute Microbiome measurements in epidemiological studies.

Actinobact

eria

Bactero

idetes

Firmicu

tes

Fuso

bacteri

a

Proteo

bacteri

a

PD_tree

Chao1

Observe

d_speci

es

Shan

non_index

Unweighted

Weig

hted0

0.10.20.30.40.50.60.70.8

0.51 0.48 0.52

0.650000000000001

0.570.47 0.440.48 0.5 0.48

0.690000000000001

0.520.45

0.4

0.640000000000001

0.47 0.5

0.610000000000001

0.4

NCI_Stool HMP_Stool HMP_Oral HMP_Anteriornares HMP_Skin HMP_Vagina

relative abundance α-diversity β-diversity

ICC

Temporal Variability Based on HMP Data

Page 11: National Cancer Institute Microbiome measurements in epidemiological studies.

Actinobact

eria

Bactero

idetes

Firmicu

tes

Fuso

bacteri

a

Proteo

bacteri

a

PD_tree

Chao1

Observe

d_speci

es

Shan

non_index

Unweighted

Weig

hted0

0.10.20.30.40.50.60.70.8

0.51 0.48

0.610000000000001

0.52

0.650000000000001

0.570.47 0.440.48 0.5 0.48

0.690000000000001

0.520.45

0.4

0.640000000000001

0.47 0.5

0.610000000000001

0.4

NCI_Stool HMP_Stool HMP_Oral HMP_Anteriornares HMP_Skin HMP_Vagina

relative abundance α-diversity β-diversity

ICC

Temporal Variability Based on HMP Data

average ICC for top five PCoA scores

Page 12: National Cancer Institute Microbiome measurements in epidemiological studies.

Temporal Variability Based on HMP Data

Page 13: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

MBQC ICCs

Page 14: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

4. Replication of findings• Observational studies require many independent similar

findings before we draw conclusions or consider intervention

• requires harmonizing the exposure metric• α-diversity seems easy enough

• interpolation of study means could be employed• β-diversity metrics may be hard

• allows quantification of the consistency

Page 15: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Meta-analysis

Regular aspirin use and risk of esophageal/gastric cancer

Page 16: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Publication bias

Page 17: National Cancer Institute Microbiome measurements in epidemiological studies.

Nati

onal

Can

cer I

nstit

ute

Four major concerns for microbiome

1. Study design - prospective2. Efficient biosample collections3. Stability of exposure metrics4. Replication of findings